Sakai K, Nishiuchi T, Tange S, Suzuki Y, Yano S, Terashima M, Suzuki T, Matsumoto K. Proteasomal degradation of polycomb-group

protein CBX6 confers MMP-2 expression essential for mesothelioma invasion. Scientific Reports, 10: 16678, 2020.

Sato H, Suga H, Matsumoto K, Sakai K. Cyclic peptide-based biologics regulating HGF-MET. Int J Mol Sci, 21: 7977, 2020.

Sakai K, Passioura T, Sato H, Ito K, Furuhashi H, Umitsu M, Takagi J, Kato Y, Mukai H, Warashina S, Zouda M, Watanabe Y, Yano S,

Shibata M, Suga H§, Matsumoto K§. Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor. Nature Chem Biol, 15: 598-606, 2019.

Jangphattananont N, Sato H, Imamura R, Sakai K, Terakado Y, Murakami K, Barker N, Oshima H, Oshima M, Takagi J, Kato Y, Yano S,

Matsumoto K. Distinct localization of mature HGF from its precursor form in developing and repairing stomach. Int J Mol Sci, 20: 2944, 2019.

Miao W, Sakai K, Ozawa N, Nishiuchi T, Suzuki Y, Ito K, Morioka T, Umitsu M, Takagi J, Suga H, Matsumoto K. Cellular signaling and

gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist. Scientific Rep, 8: 16492, 2018.

Imamura R, Matsumoto K. Hepatocyte growth factor in physiology and infectious diseases. Cytokine, 98: 97-106, 2017.

Adachi E, Sakai K, Nishiuchi T, Imamura R, Sato H, Matsumoto K. Cell-autonomous changes in Met receptor expression regulate the

growth and metastatic characteristics in malignant melanoma. Oncotarget, 7: 70779-70793, 2016.

Ito K†, Sakai K†, Suzuki Y, Ozawa N, Hatta T, Natsume T, Matsumoto K§, Suga H§. Artificial human Met agonists based on

macrocycle scaffolds. Nature Commun, 6: 6373, 2015.

Matsumoto K, Yoshitomi H, Rossant J, Zaret K. Liver organogenesis promoted by endothelial cells prior to vascular function.

Science, 294: 559-563, 2001.

Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth

factor. Cell, 67: 901-908, 1991.